Picture of Guerbet SA logo

GBT Guerbet SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Brief: Guerbet Maintains 2020 Objectives Reported With Its Half-Year Results

Oct 22 (Reuters) - Guerbet SA  GRBT.PA :
    * REG-GUERBET: REVENUE AT SEPTEMBER 30, 2020
    * AT SEPTEMBER 30, 2020, REPORTED REVENUE WAS EUR 536.0
MILLION
    * IS MAINTAINING OBJECTIVES REPORTED WITH ITS HALF-YEAR
RESULTS
    * IN COMING MONTHS, GROUP'S ACTIVITY IS EXPECTED TO BE
AFFECTED BY
INITIAL SALES OF GENERIC OF DOTAREM® IN UNITED STATES.
    * GUERBET SHOULD CONTINUE TO BENEFIT FROM GOOD PERFORMANCE
OF
LIPIODOL® AND STRENGTH OF XENETIX® AND OPTIRAY®.
    * GROUP EXPECTS EBITDA FOR 2020 FINANCIAL YEAR TO BE AROUND
14% OF
REVENUE.
    * IS CONFIDENT THAT IT CAN LOWER ITS LEVEL OF STRUCTURAL
COSTS FOR
LONG TERM WITH EXPECTATIONS OF A VERY FAVORABLE IMPACT ON
PROFITABILITY ONCE BUSINESS IS BACK TO NORMAL.

Source text for Eikon: [ID: nGNX6ZqKgp]
Further company coverage:  GRBT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Guerbet SA

See all news